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Coordinate integrin and c-Met 
signaling regulates Wnt gene 
expression during  
kidney development
Although integrins signal through multiple biochemical path-
ways, there is limited information relating distinct pathways 
to specific biological processes in tissues and organs. Inac-
tivation of the β1 integrin gene in mice results in very early 
embryonic lethality, but mutation of distinct α-subunits that 
heterodimerize with β1 has provided information about the 
function of different integrin heterodimers. In the kidney, 
it was found that deletion of the α3 integrin gene leads to 
several malformations, particularly in glomeruli and papillae. 
Interestingly, in the presence of α3β1 integrin, β-catenin lev-
els were found to be increased, suggesting increased Wnt sig-
naling through the canonical Wnt pathway by this integrin. 
In a recent study, Liu et al. found that α3β1 integrin (a 
major laminin receptor) and c-Met, the receptor for hepa-
tocyte growth factor (Hgf), signal coordinately to regulate 
the expression of Wnt7b in the kidney. They also found 
that Wnt7b expression was markedly decreased in an α3β1 
integrin-deficient (KO) collecting duct epithelial cell line or 
in a cell line expressing the laminin-binding mutant of the α3 
integrin subunit. In situ hybridization of wild-type and α3β1 
integrin KO kidneys also showed α3β1 integrin-dependent 
expression of the Wnt7b transcripts in the developing 
papilla (Figure), indicating that the α3β1 integrin regulates 
the expression of Wnt7b in the developing kidney. Because 
integrins and growth factor receptors signal coordinately to 
integrate signaling by soluble growth factors and the ECM, 
the authors next investigated whether α3β1 integrin interacts 
with a growth factor receptor to stimulate Wnt gene expres-
sion, and found that the Hgf receptor c-Met regulated the 
expression of Wnt7b. Thus, these results suggest a novel role 
of α3β1 integrin: acting coordinately with c-Met to regulate 
Wnt gene expression, which in turn can regulate cell survival 
and contribute to the proper development of the renal papilla. 
(Development 2009; 136: 843–853; doi:10.1242/dev.027805)
Juan Oliver
Potassium increases  
nitric oxide release
In contrast to sodium, potassium intake has been shown to 
lower blood pressure. It was recently found that small physi-
ological changes in extracellular sodium concentration directly 
stiffened vascular endothelium, and that this effect was blocked 
by amiloride. Oberleithner et al. recently examined the effect of 
extracellular potassium on endothelial-cell stiffness and nitric 
oxide (NO) production. Using atomic-force microscopy imag-
ing of living endothelial cells, they found that cell height and 
cell volume increased when extracellular potassium was raised 
in a stepwise fashion from 4 mM to 6 mM and 8 mM. Addition 
of barium to the media prevented changes in cell volume when 
potassium was increased, suggesting that endothelial cells have 
active potassium channels in the plasma membrane. Nitrite con-
centration (used as an index of NO release into the medium) in 
the media bathing the cells was found to be constant at extracel-
lular potassium concentrations between 2 and 4 mM. However, 
a further increase to 6 and 8 mM shifted nitrite concentration 
to higher levels, indicating an increased release of NO into the 
supernatant. Interestingly, when aldosterone was present in the 
culture medium (Figure), nitrite formation was significantly 
decreased at potassium concentrations of 2, 4, and 6 mM and 
was unaffected by increases in potassium concentration between 
2 and 6 mM. Only when potassium was increased to 8 mM were 
higher nitrite concentrations detected in the supernatant. When 
the cells were cultured in high-sodium medium in the pres-
ence of aldosterone, cells did not respond anymore to changes 
of extracellular potassium between 2 and 8 mM. Thus, the find-
ings suggest that high extracellular potassium can stimulate NO 
release as long as ambient sodium concentration is low, and that 
aldosterone modulates NO release by potassium. These studies, 
together with previous work, show that extracellular sodium 
and potassium, by different mechanisms, determine the physical 
compliance and function of endothelial cells and that aldoster-
one is an important modifier of this process. Such a mechanism 
appears to regulate endothelial deformability and NO release, 
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Differential expression of Wnt7b transcripts in wild-type (WT) and α3β1 
integrin KO papillae (P).
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Nitrite concentrations in the supernatant culture media after exposure of 
the endothelial cells for 24 hours to different potassium concentrations. 
Three series of experiments were performed (low sodium, low sodium 
plus aldosterone, and high sodium plus aldosterone).
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and thus may influence blood pressure. (Proc Natl Acad Sci USA 
2009; 106: 2829–2834; doi:10.1073/pnas.0813069106)
Juan Oliver
Long-term consequences  
of kidney donation
The modest increase in recent years in kidney transplantation 
rates has been attributed almost entirely to a rise in living kidney 
donors. Although many studies provide insight into the long-term 
outcomes of persons who donate a kidney, these studies have defi-
nite method ological limitations.
Now, a new study by Ibrahim et al. describes the risks associ-
ated with kidney donation in 3698 donors from 1963 to 2007 at 
the University of Minnesota. Glomerular filtration rate (GFR), 
urinary albumin excretion, the presence of hypertension, gen-
eral health status, and quality of life were measured in a sub-
set of 255 donors. Kidney donors had a similar survival rate 
of approximately 80% 30 years after donation compared with 
controls from the National Health and Nutrition Examination 
Survey (matched for age, sex, and race or ethnic group). End-
stage renal disease (ESRD) developed in 11 donors at a mean 
of 22.5 years after donation. The rate of ESRD among donors 
was 180 cases per million persons per year, as compared with a 
rate of 268 per million per year in the general population. Only 
three of the 11 donors who developed ESRD had the same cause 
of ESRD as their recipients. At the time of donation, the mean 
serum creatinine level of the donors was measured at 0.9 ± 0.2 
mg/dl with an estimated GFR (eGFR) of 84.0 ± 13.8 ml/min. 
Repeat assessment in the subset of 255 donors was performed at 
a mean time of 12.2 ± 9.2 years after donation. At that time, the 
mean serum creatinine level was 1.1 ± 0.2 mg/dl, and the eGFR 
was 63.7 ± 11.9 ml/min. A younger age at the time of donation, 
a longer time since donation, and a higher eGFR at the time of 
donation were associated with a greater compensatory increase in 
the eGFR in the remaining kidney. It was further estimated that 
each year after donation was associated with an increase in GFR 
of 0.20 ml/min. With respect to the presence of self-reported 
clinical conditions of diabetes mellitus, cancer, coronary heart 
disease, cerebrovascular disease, and hypertension, donors had 
a risk similar to that of their matched comparison cohort.
This study undoubtedly provides the best data to date for 
potential living donors regarding the risks associated with 
their acts of altruism. It will definitively provide significant 
support to their ability to give informed consent. The only 
significant limitation of this landmark work is that of race. 
Because this was a single-center study, the racial composition 
of those receiving transplants was 98.8% white. With the recent 
discovery of a genetic link within African-American families 
to kidney disease related to a mutation at the MH9 gene,1 it is 
not clear whether these rates can be applied to blacks. (N Engl 
J Med 2009; 360: 459–469)
Lynda Szczech
1Nat Genet 2008; 40: 1175–1184.
Acute kidney injury  
after hepatic ischemia and 
reperfusion injury in mice
Hepatic ischemia–reperfusion (IR) is the leading cause of acute 
liver failure (ALF) during the perioperative period. Patients with 
ALF frequently develop acute kidney injury (AKI). There is no 
effective therapy for AKI associated with ALF, because patho-
mechanisms are incompletely characterized, in part because of the 
lack of an animal model. In a new study, Lee et al. characterized a 
novel murine model of AKI following hepatic IR. Mice subjected to 
approximately 70% liver IR not only developed acute liver dysfunc-
tion but also developed severe AKI 24 hours after liver injury. Mice 
subjected to liver IR developed histological changes of acute tubu-
lar injury, including focal proximal tubular cell necrosis involving 
the S3 segment, cortical tubular ectasia, focal tubular simplifica-
tion, and granular bile/heme cast formation (Figure). They also 
developed focal interstitial edema and hyperplasia of the juxta-
glomerular apparatus. Inflammatory changes in the kidney after 
hepatic IR included neutrophil infiltration of the interstitium and 
upregulation of several proinflammatory mRNAs (tumor necro-
sis factor-α, keratinocyte-derived cytokine, monocyte chemotac-
tic protein-1, macrophage inflammatory protein-2, intercellular 
adhesion molecule-1). In addition, marked renal endothelial cell 
apoptosis was detected involving peritubular interstitial capillar-
ies, accompanied by increased renal vascular permeability. Finally, 
severe disruption of renal proximal tubule epithelial filamentous-
actin took place. These results show that AKI rapidly and repro-
ducibly develops in mice after hepatic IR and is characterized by 
renal tubular necrosis, inflammatory changes, and interstitial capil-
lary endothelial apoptosis. Such a murine model of AKI after liver 
injury closely mimics human AKI associated with ALF and may 
be useful in delineating the mechanisms of and potential therapies 
for this common clinical condition. (Lab Invest 2009; 89: 196–208; 
doi:10.1038/labinvest.2008.124)
Marc De Broe
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Representative photomicrographs of five experiments (hematoxylin and 
eosin staining) of mice subjected to sham operation or to liver IR injury. 
